LN-145

Drug identity checked against registry records

Also recorded as TIL, Autologous Tumor Infiltrating Lymphocytes; TIL, autologous tumor infiltrating lymphocytes

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.